Immunic reported 197K in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
BioMarin Pharmaceutical USD 55.63M 7.67M Sep/2026
Cipla INR 167.4M 2.9M Sep/2026
Compugen USD 1.84M 485K Jun/2026
CSL USD 215M 111M Dec/2025
Enanta Pharmaceuticals USD 1.96M 620K Dec/2024
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 197K 222K Dec/2025
Insmed USD 20.41M 1.57M Sep/2026
Omeros USD 4.05M 5.16M Sep/2024
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.78B 66M Sep/2026
Ultragenyx Pharmaceutical USD 20M 2M Sep/2026
United Therapeutics USD 2.9M 0 Sep/2026